Name
GS1-04: Tumor infiltrating lymphocytes and pathologic complete response in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab - Commentary by: Matteo Lambertini, MD, PhD
Date & Time
Tuesday, December 2, 2025
Speakers
Virtual Session Link
Total Minutes
04:59
OnDemand Video URL